Citation | Chen, C; Wilcoxen, KM; Huang, CQ; Xie, YF; McCarthy, JR; Webb, TR; Zhu, YF; Saunders, J; Liu, XJ; Chen, TK; Bozigian, H; Grigoriadis, DE Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists. J Med Chem47:4787-98 (2004) [PubMed] Article |
---|
SMILES | CCCN(CCC)c1cc(C)nc2c(c(C)nn12)-c1c(C)cc(nc1C)N(C)C |(4,5.65,;4.49,4.17,;3.47,3.03,;3.96,1.57,;5.47,1.26,;6.5,2.4,;8,2.09,;2.92,.41,;3.41,-1.04,;2.39,-2.2,;2.87,-3.65,;.89,-1.87,;.41,-.41,;-1,.2,;-.86,1.75,;-2.01,2.76,;.66,2.06,;1.43,.72,;-2.33,-.58,;-3.68,.19,;-3.69,1.75,;-5.02,-.58,;-5.02,-2.13,;-3.68,-2.91,;-2.33,-2.13,;-1,-2.91,;-6.36,-2.91,;-7.68,-2.13,;-6.36,-4.45,)| |